Header Logo

Connection

ANNE TSAO to Patient Reported Outcome Measures

Back to Details
This is a "connection" page, showing publications ANNE TSAO has written about Patient Reported Outcome Measures.
ANNE TSAO
Connection Strength
0.032
Patient Reported Outcome Measures
  1. First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743. Lung Cancer. 2022 05; 167:8-16.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.